Literature

Curbside Consults Podcast

Clinical Diagnosis and Management of Hyperparathyroidism with Dr. Ole-Petter Hamnvik

Published February 25, 2021

In this episode of Curbside Consults, we discuss the diagnosis and management of primary, secondary, and tertiary hyperparathyroidism with Dr. O.P. Hamnvik, who is an endocrinologist and educator at the Brigham and Women’s Hospital in Boston and the NEJM Group Education Editor.

0:05 – Intro
 0:50 – Description of hyperparathyroidism
 1:40 – Prevalence of primary hyperparathyroidism
 2:00 – Causes of primary hyperparathyroidism
 3:20 – Signs and symptoms of primary hyperparathyroidism
 4:35 – Laboratory investigations for primary hyperparathyroidism
 6:20 – Imaging studies for primary hyperparathyroidism
 8:40 – Asymptomatic primary hyperparathyroidism
 10:42 – Medical management for primary hyperparathyroidism
 11:25 – Complications of parathyroid surgery
 12:50 – Long-term follow up post parathyroid surgery for primary hyperparathyroidism
 13:00 – Secondary hyperparathyroidism
 14:20 – Management of secondary hyperparathyroidism
 15:20 – Tertiary hyperparathyroidism
 17:30 – Treatment of tertiary hyperparathyroidism
 19:03 – Outro

Resources and articles discussed in this episode:

1. Insonga K. Primary Hyperparathyroidism. N Engl J Med 2018.
2. Vodopivec D et al. Looking for the Outsider. N Engl J Med 2020.

The Curbside Consults series complements the foundational information in Rotation Prep by taking a deep dive into key clinical topics with expert clinicians and educators. These podcasts explore and critique the evidence behind clinical practice and break down statistical concepts for the busy clinical trainee.

res360
Dr. Hamnvik is an endocrinologist and educator at Brigham and Women’s Hospital and Harvard Medical School in Boston. He is a core faculty in the HMS endocrine course; an advisor for HMS medical students during their clinical years; an assistant program director for the internal medicine residency program and an associate program director for the endocrinology fellowship program at Brigham and Women’s Hospital; and also involved in several continuing medical education courses.
res360
James is a 2020-2021 NEJM Editorial Fellow and a graduate of the National University of Ireland, Galway. He has a Masters of Science in Evidence-Based Healthcare from University College London and completed Basic Specialist Training in general internal medicine with the Royal College of Physicians in Ireland.